Impact of empagliflozin on left atrial mechanical and conduction functions in patients with type 2 diabetes mellitus.
empagliflozin對2型糖尿病患者左心房機械和傳導功能的影響。
J Clin Ultrasound 2023-03-13
Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus.
二型糖尿病患者達帕格列酮對心包脂肪組織和左心室收縮功能的超聲心動圖評估。
J Diabetes Complications 2023-12-15
Effects of 3-month dapagliflozin on left atrial function in treatment-naïve patients with type 2 diabetes mellitus: Assessment using 4-dimensional echocardiography.
3個月達帕格列酮對於初次接受治療的2型糖尿病患者左心房功能的影響:以四維超聲心動圖評估。
Hellenic J Cardiol 2023-12-23
Impact of sodium glucose co-transporter-2 inhibitors on left atrial functions in patients with type-2 diabetes and heart failure with mildly reduced ejection fraction.
SGLT-2 抑制劑對2型糖尿病合併心臟衰竭且左心室射血分數輕度降低患者的左心房功能影響。
Int J Cardiol Heart Vasc 2024-01-09
Assessing the early prognosis of heart failure after acute myocardial infarction using left ventricular pressure-strain loop: a prospective randomized controlled clinical study.
使用左心室壓力-應變迴圈評估急性心肌梗塞後心力衰竭的早期預後:一項前瞻性隨機對照臨床研究。
Quant Imaging Med Surg 2024-02-29
Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndrome.
急性冠狀動脈症候群後早期使用SGLT2抑制劑與改善左心房應變相關。
Acta Cardiol 2024-04-18
Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment.
糖尿病患者在 empagliflozin 治療後心臟肌肉應變和功率的改善。
J Diabetes Investig 2024-03-27
Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function.
利拉魯肽、恩帕格列酮及其聯合應用對左心房應變和動脈功能的影響。
Medicina (Kaunas) 2024-04-08
Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.
Empagliflozin 與 2 型糖尿病合併冠狀動脈疾病患者的左心房功能:來自 EMPA-HEART CardioLink-6 隨機臨床試驗的見解。
Cardiovasc Diabetol 2024-08-28
The effects of SGLT-2 inhibitors on echocardiographic indices and antioxidative properties in patients with heart failure with reduced ejection fraction and diabetes mellitus.
SGLT-2 抑制劑對於心臟射出分數降低及糖尿病患者的超聲心動圖指標和抗氧化特性的影響。
Eur Rev Med Pharmacol Sci 2024-09-04